Boundless Bio
BOLD
55 hedge funds and large institutions have $37.6M invested in Boundless Bio in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 4 reducing their positions, and 9 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 4
0% more funds holding
Funds holding: 55 → 55 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
1.51% less ownership
Funds ownership: 59.64% → 58.13% (-1.5%)
18% less capital invested
Capital invested by funds: $46.1M → $37.6M (-$8.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$701K |
| 2 |
AC
Almitas Capital
Santa Monica,
California
|
+$559K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$347K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$253K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$210K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.14M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$826K |
| 3 |
Norges Bank
Oslo,
Norway
|
-$546K |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$204K |
| 5 |
Renaissance Technologies
New York
|
-$99.6K |
BOLD Hedge Fund Activity: Q4 2024 in Review
55 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Boundless Bio (BOLD) for Q4 2024, worth a combined $37.6M — down 18% from $46.1M a quarter earlier.
Fund positioning in BOLD was balanced in Q4 2024: 9 funds opened new positions, 9 closed out, 28 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock, adding an estimated $701K. The largest seller was Wellington Management Group, cutting an estimated $1.14M.
- 55 institutional investors held Boundless Bio (BOLD) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $37.6M of Boundless Bio stock for Q4 2024, down 18% quarter-over-quarter.
- 9 funds opened new Boundless Bio positions in Q4 2024 and 9 closed out, a net change of 0 holders.
- The largest Boundless Bio buyer in Q4 2024 was BlackRock, an estimated $701K added.
- The largest Boundless Bio seller in Q4 2024 was Wellington Management Group, an estimated $1.14M sold.
Based on aggregated 13F filings for Q4 2024.